Nutrients 6, 2552-2571 (2014)
GLP-1 Agonists Show Promise in Treating Substance Use Disorders Nov 7, 2025 5 min read Updated: Dec 17, 2025 In recent years, medications originally developed to treat Type 2 diabetes, obesity, and other weight-related conditionssuch as semaglutide and liraglutideare showing promise in treating substance use disorders (SUDs)
Powerful Anti-Aging Treatments at ageRejuvenation Is Potassium a Super Nutrient
After 2 h the resin was filtered and discarded
GLP-1 increases insulin sensitivity and balances blood sugar levels
Furthermore, PLC-1 siRNA was used to transfect hepatocellular carcinoma cell lines, and it was found that the role of the above signal pathway was obviously weakened during the metastasis of HCC cells with low expression of PLC-1